← Browse by Condition
Medical Condition

metastatic castration resistant prostate neoplasms

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05818683 Phase 1
Recruiting

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer

Enrollment
277 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
View Trial →